Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Arcturus Therapeutics Holdings Inc
Change in Working Capital
Arcturus Therapeutics Holdings Inc
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
|
Change in Working Capital
$79.7m
|
CAGR 3-Years
44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
43%
|
|
Abbvie Inc
NYSE:ABBV
|
Change in Working Capital
$3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
38%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Change in Working Capital
-$2.2B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
Amgen Inc
NASDAQ:AMGN
|
Change in Working Capital
-$422m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Change in Working Capital
-$275.3m
|
CAGR 3-Years
-158%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Change in Working Capital
$105.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Arcturus Therapeutics Holdings Inc's Change in Working Capital?
Change in Working Capital
79.7m
USD
Based on the financial report for Mar 31, 2024, Arcturus Therapeutics Holdings Inc's Change in Working Capital amounts to 79.7m USD.
What is Arcturus Therapeutics Holdings Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
43%
The average annual Change in Working Capital growth rates for Arcturus Therapeutics Holdings Inc have been 44% over the past three years , and 43% over the past ten years .